%PDF-1.4
1 0 obj
<<
/Type /Catalog
/Pages 2 0 R
>>
endobj

2 0 obj
<<
/Type /Pages
/Kids [3 0 R]
/Count 1
>>
endobj

3 0 obj
<<
/Type /Page
/Parent 2 0 R
/MediaBox [0 0 612 792]
/Contents 4 0 R
/Resources <<
/Font <<
/F1 5 0 R
/F2 6 0 R
/F3 7 0 R
>>
>>
>>
endobj

4 0 obj
<<
/Length 2000
>>
stream
BT
/F1 16 Tf
50 750 Td
(PROSTATE BIOPSY REPORT - DAVID BROWN) Tj
0 -30 Td
/F2 10 Tf
(Report ID: BX-2024-001239 | Date: 12/10/2024) Tj
0 -30 Td
/F1 14 Tf
(PATIENT INFORMATION) Tj
0 -20 Td
/F2 10 Tf
(Name: David Michael Brown             DOB: 11/30/1968) Tj
0 -15 Td
(MRN: 567890123              Procedure Date: 12/10/2024) Tj
0 -15 Td
(Referring Physician: Dr. Christopher Lee, MD - Urology) Tj
0 -15 Td
(Clinical History: Elevated PSA 8.5 ng/mL, abnormal DRE) Tj
0 -30 Td
/F1 14 Tf
(PROCEDURE INFORMATION) Tj
0 -20 Td
/F2 10 Tf
(Procedure: Transrectal Ultrasound-Guided Prostate Biopsy) Tj
0 -15 Td
(Number of Cores: 12 cores (6 from each lobe)) Tj
0 -15 Td
(Anesthesia: Local anesthesia with sedation) Tj
0 -15 Td
(Complications: None) Tj
0 -15 Td
(Post-procedure: Patient tolerated procedure well) Tj
0 -30 Td
/F1 14 Tf
(GROSS DESCRIPTION) Tj
0 -20 Td
/F2 10 Tf
(Twelve core needle biopsies of the prostate, each measuring) Tj
0 -12 Td
(approximately 1.5 cm in length and 0.1 cm in diameter.) Tj
0 -15 Td
(Cores are submitted in separate containers labeled A through L.) Tj
0 -15 Td
(All cores are processed and examined.) Tj
0 -30 Td
/F1 14 Tf
(MICROSCOPIC DESCRIPTION) Tj
0 -20 Td
/F2 10 Tf
(Core A (Right apex): Benign prostatic tissue) Tj
0 -15 Td
(Core B (Right mid): Benign prostatic tissue) Tj
0 -15 Td
(Core C (Right base): Benign prostatic tissue) Tj
0 -15 Td
(Core D (Left apex): Benign prostatic tissue) Tj
0 -15 Td
(Core E (Left mid): Benign prostatic tissue) Tj
0 -15 Td
(Core F (Left base): Benign prostatic tissue) Tj
0 -15 Td
(Core G (Right lateral): Adenocarcinoma, Gleason score 7 (3+4)) Tj
0 -15 Td
(Core H (Right lateral): Adenocarcinoma, Gleason score 7 (3+4)) Tj
0 -15 Td
(Core I (Left lateral): Benign prostatic tissue) Tj
0 -15 Td
(Core J (Left lateral): Benign prostatic tissue) Tj
0 -15 Td
(Core K (Right posterior): Adenocarcinoma, Gleason score 7 (3+4)) Tj
0 -15 Td
(Core L (Left posterior): Benign prostatic tissue) Tj
0 -30 Td
/F1 14 Tf
(ADENOCARCINOMA CHARACTERISTICS) Tj
0 -20 Td
/F2 10 Tf
(Gleason Score: 7 (3+4)) Tj
0 -15 Td
(Percentage of Cancer: 30% of total cores) Tj
0 -15 Td
(Perineural Invasion: Not identified) Tj
0 -15 Td
(Lymphovascular Invasion: Not identified) Tj
0 -15 Td
(Extraprostatic Extension: Not identified) Tj
0 -15 Td
(Seminal Vesicle Involvement: Not identified) Tj
0 -15 Td
(Margin Status: Not applicable (needle biopsy)) Tj
0 -30 Td
/F1 14 Tf
(IMPRESSION) Tj
0 -20 Td
/F2 10 Tf
(1. ADENOCARCINOMA OF THE PROSTATE) Tj
0 -15 Td
(   Gleason score 7 (3+4) in 3 of 12 cores (25%)) Tj
0 -15 Td
(   Involved cores: Right lateral (2 cores), Right posterior (1 core)) Tj
0 -15 Td
(2. No evidence of perineural invasion) Tj
0 -15 Td
(3. No evidence of lymphovascular invasion) Tj
0 -15 Td
(4. No evidence of extraprostatic extension) Tj
0 -20 Td
(RECOMMENDATIONS:) Tj
0 -15 Td
(1. Consider staging studies (CT chest/abdomen/pelvis, bone scan)) Tj
0 -15 Td
(2. Discuss treatment options with urologist) Tj
0 -15 Td
(3. Consider active surveillance vs. definitive treatment) Tj
0 -15 Td
(4. Follow-up PSA in 3 months) Tj
0 -30 Td
/F3 8 Tf
(Pathologist: Dr. Patricia Williams, MD | Date: 12/12/2024 | E-Signature: Applied) Tj
0 -15 Td
(Report ID: BX-2024-001239 | Timestamp: 12/12/2024 14:20:15) Tj
ET
endstream
endobj

5 0 obj
<<
/Type /Font
/Subtype /Type1
/BaseFont /Helvetica-Bold
>>
endobj

6 0 obj
<<
/Type /Font
/Subtype /Type1
/BaseFont /Helvetica
>>
endobj

7 0 obj
<<
/Type /Font
/Subtype /Type1
/BaseFont /Helvetica-Oblique
>>
endobj

xref
0 8
0000000000 65535 f 
0000000009 00000 n 
0000000058 00000 n 
0000000115 00000 n 
0000000274 00000 n 
0000002274 00000 n 
0000002524 00000 n 
0000002774 00000 n 
trailer
<<
/Size 8
/Root 1 0 R
>>
startxref
2875
%%EOF
